Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by ReShape Lifesciences Inc.

ReShape Reports Second Quarter 2021 Financial Results and Provides Business Update
From ReShape Lifesciences Inc.
Via AccessWire
Tickers RSLS
ReShape Lifesciences Reports Preliminary Unaudited Second Quarter 2021 Financial Results and Provides Business Update
From ReShape Lifesciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Tickers RSLS
ReShape Lifesciences(TM) CEO Bart Bandy Featured on the Big Biz Show
From ReShape Lifesciences Inc.
Via AccessWire
Tickers RSLS
ReShape Lifesciences to Report Second Quarter 2021 Financial and Operational Results on Thursday, August 5, 2021
From ReShape Lifesciences Inc.
Via AccessWire
Tickers RSLS
ReShape Lifesciences(TM) Launches Online Consumer Marketplace Offering Products Supporting Four Key Dimensions of Wellness: Nutrition, Exercise, Sleep and Stress
From ReShape Lifesciences Inc.
Via AccessWire
Tickers RSLS
ReShape Lifesciences Moves Lap-Band Manufacturing to United States
From ReShape Lifesciences Inc.
Via AccessWire
Tickers RSLS
ReShape Lifesciences Sees Lap-Band Growth as COVID-19 Pandemic Heightens Obesity Crisis
From ReShape Lifesciences Inc.
Via AccessWire
Exposures COVID-19
Tickers RSLS
ReShape Lifesciences Completes $46 Million Capital Raise With Key Institutional Shareholders
From ReShape Lifesciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Tickers RSLS
ReShape Lifesciences Enters into Warrant Exercise Transaction for $46.2 Million in Gross Proceeds
From ReShape Lifesciences Inc.
Via AccessWire
Tickers RSLS
ReShape Lifesciences Closes First Day of Trading on the NASDAQ Capital Market
From ReShape Lifesciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Tickers RSLS
ReShape Lifesciences Completes Merger with Obalon Therapeutics
From ReShape Lifesciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Product Safety Regulatory
Tickers RSLS
ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Announce Anticipated Closing of Merger
From ReShape Lifesciences Inc.
Via AccessWire
Tickers RSLS
ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending Merger
From ReShape Lifesciences Inc.
Via AccessWire
Tickers RSLS
Reminder: Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences
From ReShape Lifesciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Tickers RSLS
Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences
From ReShape Lifesciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Tickers RSLS
Obalon Therapeutics Stockholders Special Meeting Adjourned to May 25, 2021
From ReShape Lifesciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Tickers RSLS
ReShape Lifesciences Announces First Quarter 2021 Financial and Operational Results
From ReShape Lifesciences Inc.
Via AccessWire
Topics Fraud Intellectual Property
Exposures COVID-19 Intellectual Property Legal
Tickers RSLS
Obalon Therapeutics, Inc. Urges Stockholders to IMMEDIATELY Vote FOR All Proposals Related to the Merger with ReShape Lifesciences Inc
From ReShape Lifesciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback